HealthDay News — During August 2021 to August 2023, only 36.4% of US adults had no cardiovascular disease (CVD) risk factors, according to a September data brief published by the National Center for ...
HealthDay News — The US Food and Drug Administration (FDA) has approved a subcutaneous (SC) induction regimen of Tremfya (guselkumab) for the treatment of adults with moderately to severely active ...
Researchers explored the impact of polypharmacy on long-term treatment response among patients with early rheumatoid arthritis.
Psychosocial symptoms improved with encounters with a behavioral health clinician and psychotropic prescription.
North Carolina and Idaho are cutting their Medicaid programs to bridge budget gaps, raising fears that providers will stop taking patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback